These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9838339)

  • 41. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC; Park SB; Kim HT; Cho WH; Park CH
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment.
    Koo KH; Kim R; Kim YS; Ahn IO; Cho SH; Song HR; Park YS; Kim H; Wang GJ
    Clin Rheumatol; 2002 Aug; 21(4):299-303. PubMed ID: 12189457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
    Ratcliffe PJ; Dudley CR; Higgins RM; Firth JD; Smith B; Morris PJ
    Lancet; 1996 Sep; 348(9028):643-8. PubMed ID: 8782754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcome of living-unrelated donor kidney transplantation.
    Prabhakar KS; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1807-8. PubMed ID: 11119945
    [No Abstract]   [Full Text] [Related]  

  • 45. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.
    Hjelmesaeth J; Hartmann A; Kofstad J; Stenstrøm J; Leivestad T; Egeland T; Fauchald P
    Transplantation; 1997 Oct; 64(7):979-83. PubMed ID: 9381545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
    Kliem V; Petersen R; Ehlerding G; Schaumann D; Eisenberger U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1251-3. PubMed ID: 9636509
    [No Abstract]   [Full Text] [Related]  

  • 47. Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients.
    Sartori MT; Patrassi GM; Rigotti P; Marchini F; Fioretti M; Spiezia L; Girolami A
    Transplantation; 2000 May; 69(10):2116-21. PubMed ID: 10852608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclosporin A and osteonecrosis of the femoral head.
    Rombouts JJ; Kallel S; Squifflet JP; Gianello P; Alexandre GP; Pirson Y
    J Bone Joint Surg Am; 1988 Dec; 70(10):1575. PubMed ID: 3058714
    [No Abstract]   [Full Text] [Related]  

  • 50. [Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou].
    Shen J; Liang BL; Zeng QS; Chen JY; Liu QY; Chen RC; Zhong NS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1814-7. PubMed ID: 15631780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two cases of tacrolimus-induced alopecia following kidney transplantation.
    Ushigome H; Yoshimura N; Okamoto M; Najima H; Hamajima T; Nakai I; Oka T
    Transplant Proc; 1999 Nov; 31(7):2885-6. PubMed ID: 10578326
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 53. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
    [No Abstract]   [Full Text] [Related]  

  • 54. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
    Roth D; Miller J
    Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
    [No Abstract]   [Full Text] [Related]  

  • 55. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 56. High dose steroid regime: a tool for reducing organ rejection.
    Jawad F; Naqvi A; Rizvi A
    Transplant Proc; 2001 Aug; 33(5):2786. PubMed ID: 11498160
    [No Abstract]   [Full Text] [Related]  

  • 57. Analysis of long-term results in kidney transplantation performed using a rejection-free protocol with cyclosporine and thoracic duct drainage.
    Kinukawa T; Ono Y; Takeuchi N; Hattori R; Ohshima S
    Transplant Proc; 1997; 29(1-2):946-7. PubMed ID: 9123600
    [No Abstract]   [Full Text] [Related]  

  • 58. Application of corbrin capsule in human renal transplantation.
    Min Z; Oi J; Zhu Y; Wei W
    Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813
    [No Abstract]   [Full Text] [Related]  

  • 59. Donor-specific transfusion under the new cyclosporine A formulation Consupren versus azathioprine, Imuran.
    Kamel G; Stephan A; Masri MA; Barbari A; Kelany H; Younan F; Karam A
    Transplant Proc; 1997 Nov; 29(7):2960-1. PubMed ID: 9365629
    [No Abstract]   [Full Text] [Related]  

  • 60. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.